Nasrat Hakim | Chairman, President and CEO |
Carter Ward | CFO |
Good morning, ladies and gentlemen and welcome to Elite Pharmaceuticals Conference Call. At this time, all lines have been placed on listen-only mode.
Before management begins, the Company has the following statements.
This conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to the effects, if any, on future results, performance or any other expectations that may have some correlation to the subject matter of this conference call.
Listeners are cautioned that such forward-looking statements involve risks and uncertainties including, without limitations, Elite's ability to obtain FDA approval of the transfers of the ANDAs or the timings of such approval processes, delays, uncertainties, inability to obtain necessary ingredients and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements.